Physician profile
Adham Osman
NPI 1073995981
$1,062.82
in general payments reported to CMS, 2019-2025
7 companies · $493 in 2025
The $493 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $79.86 · 2022: $19.93 · 2023: $428 · 2024: $41.30 · 2025: $493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $963.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $963.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $699.97 | 2023-2025 | Impella |
| Cvrx, INC. | $134.17 | 2023 | Barostim Neo System |
| Getinge USA Sales, LLC | $95.81 | 2023 | Cardiohelp |
| Boston Scientific Corporation | $79.86 | 2021 | |
| Abbott Laboratories | $19.93 | 2022 | |
| La Jolla Pharmaceutical Company | $19.47 | 2023 | Giapreza |
| Merck Sharp & Dohme LLC | $13.61 | 2024 | Dificid, Zerbaxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adham Osman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.